Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
letter
. 1973 Nov;49(3):554–556. doi: 10.1111/j.1476-5381.1973.tb17266.x

Effects of a new tetrahydroisoquinoline (NC-7197) in experimental cardiogenic shock

M F Ghani, R M Hopkins, J R Smith, D R Vanderipe
PMCID: PMC1776492  PMID: 4777715

Abstract

Intravenous administration of 1·0 mg/kg of NC-7197 to open and closed-chest anaesthetized dogs immediately after induction of cardiogenic shock by miliary coronary embolization resulted in significant haemodynamic improvement and prolonged survival. These results suggest that NC-7197 may prove to be valuable in the initial management of myocardial infarction complicated by hypotension and shock.

Full text

PDF
554

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. AGRESS C. M., ROSENBERG M. J., JACOBS H. I., BINDER M. J., SCHNEIDERMAN A., CLARK W. G. Protracted shock in the closed-chest dog following coronary embolization with graded microspheres. Am J Physiol. 1952 Sep;170(3):536–549. doi: 10.1152/ajplegacy.1952.170.3.536. [DOI] [PubMed] [Google Scholar]
  2. Bynum T. E., Brobmann G. F., Jacobson E. D., Su C. K. Comparison of early hemodynamic phenomena in three forms of shock in dogs. Proc Soc Exp Biol Med. 1971 Feb;136(2):601–604. doi: 10.3181/00379727-136-35320. [DOI] [PubMed] [Google Scholar]
  3. Goldberg L. I. The treatment of cardiogenic shock. VI. The search for an ideal drug. Am Heart J. 1968 Mar;75(3):416–420. doi: 10.1016/0002-8703(68)90098-7. [DOI] [PubMed] [Google Scholar]
  4. Gulotta S. J. Chlorpromazine in the treatment of cardiogenic shock. Am Heart J. 1970 Oct;80(4):570–573. doi: 10.1016/0002-8703(70)90207-3. [DOI] [PubMed] [Google Scholar]
  5. Kim S. I., Nassos T. P., Shoemaker W. C. Hemodynamic effects of an isoquinoline derivative in the treatment of hemorrhagic shock. J Surg Res. 1971 Aug;11(8):390–395. doi: 10.1016/0022-4804(71)90145-4. [DOI] [PubMed] [Google Scholar]
  6. Kuhn L. A. The treatment of cardiogenic shock. II. The use of pressor agents in the treatment of cardiogenic shock. Am Heart J. 1967 Nov;74(5):725–728. doi: 10.1016/0002-8703(67)90511-x. [DOI] [PubMed] [Google Scholar]
  7. Majid P. A., Sharma B., Taylor S. H. Phentolamine for vasodilator treatment of severe heart-failure. Lancet. 1971 Oct 2;2(7727):719–724. doi: 10.1016/s0140-6736(71)92098-8. [DOI] [PubMed] [Google Scholar]
  8. Privitera P. J., Blickenstaff T., Gaffney T. E., Mohammed S. Adrenergic blocking and cardiovascular effects of a new N-substituted tetrahydroisoquinoline (NC 7197). J Pharmacol Exp Ther. 1971 Mar;176(3):655–661. [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES